Literature DB >> 6375751

Biased selection of controls for case-control analyses of cohort studies.

J H Lubin, M H Gail.   

Abstract

It is known that unbiased estimates of the relative risk in a cohort study may be obtained by a matched case-control analysis that compares each case with a random sample of controls obtained from those at risk at the time of case incidence. Through inadvertence , or for practical or scientific reasons, a biased referent group may be selected instead. Three kinds of biasing restrictions on controls are commonly imposed: (i) the requirement that controls remain completely disease-free for a fixed time interval, (ii) the exclusion of all cases incident during observation as controls, and (iii) the exclusion, from the referent group, of subjects who develop other diseases, which may be related to the exposure of interest. The bias in estimation of the relative risk associated with each of these restrictions is evaluated under the proportional-hazards model. For several examples of cancer mortality data, the bias from (iii) appears quite small, whereas the bias from (i) can be appreciable and is mostly attributable to the bias from case exclusion (ii). The effect of random variation in the time of onset of exposure is to reduce these biases.

Entities:  

Mesh:

Year:  1984        PMID: 6375751

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  96 in total

1.  Strategies for cohort sampling under the Cox proportional hazards model, application to an AIDS clinical trial.

Authors:  S Kim; V De Gruttola
Journal:  Lifetime Data Anal       Date:  1999-06       Impact factor: 1.588

2.  Bias and efficiency in family-based gene-characterization studies: conditional, prospective, retrospective, and joint likelihoods.

Authors:  P Kraft; D C Thomas
Journal:  Am J Hum Genet       Date:  2000-03       Impact factor: 11.025

3.  First treatment with inhaled corticosteroids and the prevention of admissions to hospital for asthma.

Authors:  L Blais; S Suissa; J F Boivin; P Ernst
Journal:  Thorax       Date:  1998-12       Impact factor: 9.139

4.  A relative power table for nested matched case-control studies.

Authors:  D Pang
Journal:  Occup Environ Med       Date:  1999-01       Impact factor: 4.402

5.  Inhaled corticosteroids and the risk of diabetes among the elderly.

Authors:  Nandini Dendukuri; Lucie Blais; Jacques LeLorier
Journal:  Br J Clin Pharmacol       Date:  2002-07       Impact factor: 4.335

6.  Regular use of inhaled corticosteroids and the long term prevention of hospitalisation for asthma.

Authors:  S Suissa; P Ernst; A Kezouh
Journal:  Thorax       Date:  2002-10       Impact factor: 9.139

7.  Vulnerable Patients and Potential Harms: The Contribution of Observational Research.

Authors:  Deborah Layton
Journal:  Drug Saf       Date:  2016-04       Impact factor: 5.606

8.  Urologic care and progression to end-stage kidney disease: a Chronic Kidney Disease in Children (CKiD) nested case-control study.

Authors:  D I Chu; A G Abraham; G E Tasian; M R Denburg; M E Ross; S A Zderic; S L Furth
Journal:  J Pediatr Urol       Date:  2019-03-16       Impact factor: 1.830

9.  Angiotensin-converting enzyme inhibitor therapy and colorectal cancer risk.

Authors:  George A Makar; John H Holmes; Yu-Xiao Yang
Journal:  J Natl Cancer Inst       Date:  2014-01-15       Impact factor: 13.506

10.  Cisapride and ventricular arrhythmia.

Authors:  Sean Hennessy; Charles E Leonard; Craig Newcomb; Stephen E Kimmel; Warren B Bilker
Journal:  Br J Clin Pharmacol       Date:  2008-07-23       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.